Peptide Synthesizers Market Top players 2025
Global Peptide Synthesizers Market was Valued at US$ XX Mn in 2018, Due to Increasing Use of Peptides in Pharmaceutical Drugs
Analyst Speak:
“The Global Peptide Synthesizers Market was valued around US$ 312.2 Mn by 2018 and growing at a significant CAGR over six years forecast period 2019-2025 owing to increase in prevalence of chronic diseases such as diabetes, cancer, and obesity coupled with the increasing usage of peptides in pharmaceutical drugs”
Precision Business Insights (PBI) in its report titled “Global Peptide Synthesizers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
The global peptide synthesizers market was valued at US$ 312.2 Mn in 2018 and growing at a significant CAGR over the forecast period owing to increasing research activities by the universities and research institutes and growing number of pharmaceutical and biopharmaceutical companies coupled with the increasing demand for peptides due to their advantages over pharmaceutical drugs such as high specificity, high biological activity, ready availability, and low toxicity are expected to exhibit the growth of the market over the forecast period. Moreover, focus on development of advanced technology peptide synthesizers and growing number of FDA applications for peptide drugs are expected to exhibit the significant growth over forecast period. However, lack of unified set of regulations for therapeutic peptides is expected to hinder the growth of the market.
Global peptide synthesizers market segmented on the basis product & services, by application, and sector
Request Sample Report:
https://www.precisionbusinessinsights.com/request-sample?product_id=36118
Reagents accounted for higher revenue share
Based on Product, global peptide synthesizers market segmented into reagents and peptide synthesizers. Reagents segment market accounted for larger revenue share in 2018 and projected to dominate over the forecast period owing to increasing applications of peptides in therapeutics, gene synthesis, and drug design, and increasing research activities and research projects that involves peptide synthesizers and availability of various reagents in the market are expected to show significant growth over the forecast period.
North America leads the Global Peptide Synthesizers Market
PBI’s global peptide synthesizer’s market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America accounted for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to presence of prominent players and continuous support by the government and private sectors and development of novel technologies that can rapidly produce large quantities of customized peptides are expected to boost the growth of the market over the forecast period. Europe is expected to show significant growth rate over the forecasted years owing to presence of large number of market players in the region and development of new technologies coupled with ongoing research activities in the region.
Acquisitions & Mergers, strategic alliances and introduction of new technologies are the key strategies adopted by market players
Global peptide synthesizers market further reveals that the key player’s increasingly adopting strategies such as acquisitions & mergers, strategic alliance and introduction of new technology in the market to enhance market revenue share and gaining significant geographic presence across the region. For instance, in 2014, Bachem the leading peptide manufacturer, and GlyTech Inc. the world-leading developer of glycosylated drugs, announced that they have entered into a co-promotion agreement for GlyTech's glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing resources to enhance GlyTech's partnering efforts and GlyTech will promote Bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins. For instance, Activotec has launched its Activo-P11 Peptide Synthesizer during a recently held 29th European Peptide Symposium (EPS) in Gdansk, Poland.
Key player’s profiles in the report are CS Bio Company, Inc. (United States), Biotage AB (Sweden), Gyros Protein Technologies AB (Sweden), AAPPTec (United States), CEM Corporation (United States), Intavis Bioanalytical Instruments AG (Germany), Activotec (United Kingdom), and MultiSynTech GmbH (Germany).
Detailed Segmentation
By Application
o Vaccines
o Oncology
o Others
By Product
o Reagents
o Peptide Synthesizers
By End User
o Pharmaceutical and Biotechnology Companies
o CDMO/CRO
o Academic and Research Institutes
Geography
o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• Rest of Asia-Pacific
o Rest of World
• Brazil
• South Africa
• Saudi Arabia
• Others
For More Information:
https://www.precisionbusinessinsights.com/market-reports/peptide-synthesizers-market
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com